BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19814727)

  • 21. Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding.
    Michel AD; Chambers LJ; Clay WC; Condreay JP; Walter DS; Chessell IP
    Br J Pharmacol; 2007 May; 151(1):103-14. PubMed ID: 17339830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase.
    Panenka W; Jijon H; Herx LM; Armstrong JN; Feighan D; Wei T; Yong VW; Ransohoff RM; MacVicar BA
    J Neurosci; 2001 Sep; 21(18):7135-42. PubMed ID: 11549724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular adenosine 5'-triphosphate and lipopolysaccharide induce interleukin-1β release in canine blood.
    Spildrejorde M; Curtis SJ; Curtis BL; Sluyter R
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):105-10. PubMed ID: 24290165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA.
    Rassendren F; Buell GN; Virginio C; Collo G; North RA; Surprenant A
    J Biol Chem; 1997 Feb; 272(9):5482-6. PubMed ID: 9038151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antagonists at the human recombinant P2X7 receptor.
    Chessell IP; Michel AD; Humphrey PP
    Br J Pharmacol; 1998 Jul; 124(6):1314-20. PubMed ID: 9720806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From tyrosine to glycine: synthesis and biological activity of potent antagonists of the purinergic P2X7 receptor.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Preti D; Cruz-Lopez O; Tabrizi MA; Moorman AR; Gessi S; Fogli E; Sacchetto V; Borea PA
    J Med Chem; 2007 Jul; 50(15):3706-15. PubMed ID: 17585854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional expression of P2X7 receptors in non-neuronal cells of rat dorsal root ganglia.
    Zhang XF; Han P; Faltynek CR; Jarvis MF; Shieh CC
    Brain Res; 2005 Aug; 1052(1):63-70. PubMed ID: 16005856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells.
    Farrell AW; Gadeock S; Pupovac A; Wang B; Jalilian I; Ranson M; Sluyter R
    Biochim Biophys Acta; 2010 Nov; 1800(11):1173-82. PubMed ID: 20647033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutamate release and synapsin-I phosphorylation induced by P2X7 receptors activation in cerebellar granule neurons.
    León D; Sánchez-Nogueiro J; Marín-García P; Miras-Portugal MA
    Neurochem Int; 2008 May; 52(6):1148-59. PubMed ID: 18242779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human epidermal and monocyte-derived langerhans cells express functional P2X receptors.
    Georgiou JG; Skarratt KK; Fuller SJ; Martin CJ; Christopherson RI; Wiley JS; Sluyter R
    J Invest Dermatol; 2005 Sep; 125(3):482-90. PubMed ID: 16117789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional decreases in P2X7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells.
    Wu PY; Lin YC; Chang CL; Lu HT; Chin CH; Hsu TT; Chu D; Sun SH
    Cell Signal; 2009 Jun; 21(6):881-91. PubMed ID: 19385050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.
    Lee JY; Yu J; Cho WJ; Ko H; Kim YC
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6053-8. PubMed ID: 19800793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.
    Michel AD; Xing M; Humphrey PP
    Br J Pharmacol; 2001 Apr; 132(7):1501-8. PubMed ID: 11264244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms.
    Ward JR; West PW; Ariaans MP; Parker LC; Francis SE; Crossman DC; Sabroe I; Wilson HL
    J Biol Chem; 2010 Jul; 285(30):23147-58. PubMed ID: 20495003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P2Y
    Shen D; Shen X; Schwarz W; Grygorczyk R; Wang L
    Exp Dermatol; 2020 May; 29(5):499-508. PubMed ID: 32155290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionic effects on human recombinant P2X7 receptor function.
    Michel AD; Chessell IP; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Feb; 359(2):102-9. PubMed ID: 10048594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of P2X7-like receptor activated by adenosine triphosphate in HIT-T15 cells.
    Lee DH; Kim EG; Park KS; Jeong SW; Kong ID; Lee JW
    Pancreas; 2007 Jul; 35(1):53-62. PubMed ID: 17575546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors.
    Sluyter R; Wiley JS
    Int Immunol; 2002 Dec; 14(12):1415-21. PubMed ID: 12456589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2X7 receptor activation induces cell death and microparticle release in murine erythroleukemia cells.
    Constantinescu P; Wang B; Kovacevic K; Jalilian I; Bosman GJ; Wiley JS; Sluyter R
    Biochim Biophys Acta; 2010 Sep; 1798(9):1797-804. PubMed ID: 20529664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of the P2X(4) receptor orthologues.
    Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
    Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.